Chen, Huimin
Ma, Yiming
Wang, Dandan
Wu, Hao
Zhang, Mingchuan
Xu, Yuanyuan
Cheng, Shuxia
Funding for this research was provided by:
CSCO-Qilu cancer research fund (No. Y-Q201801–029, No. Y-Q201801–029, No. Y-Q201801–029, No. Y-Q201801–029, No. Y-Q201801–029, No. Y-Q201801–029, No. Y-Q201801–029)
Article History
Received: 14 July 2024
Accepted: 5 November 2024
First Online: 14 November 2024
Declarations
:
: This study was approved by the Medical Ethics Committee of the Affiliated Cancer Hospital of Zhengzhou University (No. 2019221). All patients signed informed consent forms.
: The study received written informed consent for publication by all patients.
: The authors declare no competing interests.